Daclizumab in the induction phase of immunosuppression in heart transplant recipients.

Annals of transplantation : quarterly of the Polish Transplantation Society

Volumn 10, Issue 3, 2005, Pages 5-10

  Petrikovits, Erik ^a   Bedanova, Helena ^a   Necas, Josef ^a   Studenik, Pavel ^a   Cerny, Jan ^a  

^a Centre of Cardiovascular and Transplant Surgery Brno   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

DACLIZUMAB; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; FEMALE; FOLLOW UP; GRAFT REJECTION; HEART TRANSPLANTATION; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; MALE; MIDDLE AGED; PATHOLOGY; TIME;

ADULT; ANTIBODIES, MONOCLONAL; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 33748447125     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)